Source: GWASCAT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
family with sequence similarity 13 member A | 0.653 | 0.462 | 1.9E-18 |
|
disease | 0.500 | None | 1.000 | 8 | 8 | 2010 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.200 | None | 1.000 | 4 | 15 | 2010 | 2019 | ||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
disease | 0.110 | None | 1.000 | 4 | 9 | 2009 | 2018 | ||||||||
|
eukaryotic elongation factor, selenocysteine-tRNA specific | 0.751 | 0.385 | 2.7E-08 |
|
disease | 0.400 | None | 1.000 | 3 | 2 | 2017 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
disease | 0.120 | None | 1.000 | 3 | 2 | 2011 | 2019 | ||||||||
|
adhesion G protein-coupled receptor G6 | 0.666 | 0.385 | 6.6E-05 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2017 | 2019 | ||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2017 | |||||||||
|
craniofacial development protein 1 | 0.619 | 0.615 | 3.7E-03 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 19 | 0.659 | 0.538 | 6.8E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2017 | 2019 | ||||||||
|
tensin 1 | 0.691 | 0.538 | 6.0E-02 |
|
disease | 0.120 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
armadillo repeat containing 2 | 0.805 | 0.115 | 2.5E-09 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
thrombospondin type 1 domain containing 4 | 0.780 | 0.269 | 4.8E-07 |
|
disease | 0.130 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
RAB4B, member RAS oncogene family | 0.890 | 0.192 | 0.67 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2017 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.160 | None | 1.000 | 2 | 5 | 2010 | 2019 | ||||||||
|
TAFA chemokine like family member 2 | 0.780 | 0.192 | 0.34 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2015 | ||||||||
|
integrator complex subunit 12 | 0.890 | 0.077 | 0.75 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2012 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
microtubule crosslinking factor 1 | 0.839 | 0.192 | 8.8E-05 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 2 | 1 | 2010 | 2019 | ||||||||
|
MIA-RAB4B readthrough (NMD candidate) | 0.821 | 0.385 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2012 | 2017 | |||||||||
|
desmoplakin | 0.514 | 0.808 | 1.00 |
|
disease | 0.420 | None | 1.000 | 2 | 1 | 2017 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1807 | 0.890 | 0.077 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | |||||||||
|
astrotactin 2 | 0.666 | 0.462 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
STN1 subunit of CST complex | 0.604 | 0.769 | 2.3E-10 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 |